A long-term study has found that patients treated with psilocybin, the active compound in psychedelic mushrooms, continued to experience relief from depression symptoms five years after treatment. Participants originally received guided psilocybin therapy in clinical trials and reported lasting improvements in mood, emotional resilience, and overall quality of life. Researchers say the findings suggest psilocybin could provide a powerful alternative to conventional antidepressants, which often r

Psilocybin, the active ingredient in "magic mushrooms," can alter perception, mood, and reality—sometimes leading to euphoria, but also fear, paranoia, or confusion. Taken as dried mushrooms, tea, or in food, its effects vary widely. Although psilocybin is considered to have low addiction potential, risks include increased heart rate, nausea, and accidental ingestion of toxic mushrooms. While some explore its potential medical uses, more research is needed to fully understand its long-term impac